Research graph

References

References from Identification of Active Chemotherapy Regimens in Advanced Biliary Tract Carcinoma: A Review of Chemotherapy Trials in the past Two Decades. Local targets link to admitted publications; unresolved targets remain external evidence.

10.1007/s11864-013-0237-5

10.1007/s11864-013-0237-5 · External reference

10.3322/caac.21166

10.3322/caac.21166 · External reference

10.1016/j.jhep.2003.11.030

10.1016/j.jhep.2003.11.030 · External reference

10.3322/caac.21208

10.3322/caac.21208 · External reference

10.1097/01.sla.0000251366.62632.d3

10.1097/01.sla.0000251366.62632.d3 · External reference

10.1056/nejm199910283411807

10.1056/nejm199910283411807 · External reference

10.1002/1097-0142(197807)42:1<330::aid-cncr2820420150>3.0.co;2-f

10.1002/1097-0142(197807)42:1<330::aid-cncr2820420150>3.0.co;2-f · External reference

10.1200/jco.2010.29.3605

10.1200/jco.2010.29.3605 · External reference

10.1200/jco.1997.15.6.2403

10.1200/jco.1997.15.6.2403 · External reference

10.1056/nejmoa0908721

10.1056/nejmoa0908721 · External reference

10.1038/sj.bjc.6603648

10.1038/sj.bjc.6603648 · External reference

Second-line chemotherapy in patients with biliary tract cancer

2011 · External reference

10.1016/j.ejca.2004.10.026

10.1016/j.ejca.2004.10.026 · External reference

10.1007/s00280-007-0673-7

10.1007/s00280-007-0673-7 · External reference

10.1093/jjco/hyg070

10.1093/jjco/hyg070 · External reference

10.1097/00001813-199806000-00004

10.1097/00001813-199806000-00004 · External reference

10.1097/00000421-200008000-00023

10.1097/00000421-200008000-00023 · External reference

10.1093/jjco/hyi131

10.1093/jjco/hyi131 · External reference

10.1097/01.coc.0000017090.36834.fe

10.1097/01.coc.0000017090.36834.fe · External reference

10.1093/jjco/hyq110

10.1093/jjco/hyq110 · External reference

10.1038/sj.bjc.6602208

10.1038/sj.bjc.6602208 · External reference

10.1200/jco.2010.28.15_suppl.4029

10.1200/jco.2010.28.15_suppl.4029 · External reference

10.1186/1471-2407-6-121

10.1186/1471-2407-6-121 · External reference

10.1093/annonc/mdf201

10.1093/annonc/mdf201 · External reference

10.1038/sj.bjc.6600543

10.1038/sj.bjc.6600543 · External reference

10.1200/jco.2011.29.15_suppl.4106

10.1200/jco.2011.29.15_suppl.4106 · External reference

10.1007/s00280-006-0380-9

10.1007/s00280-006-0380-9 · External reference

10.1093/annonc/mdg281

10.1093/annonc/mdg281 · External reference

10.1038/sj.bjc.6604178

10.1038/sj.bjc.6604178 · External reference

10.1093/annonc/mdm439

10.1093/annonc/mdm439 · External reference

10.1200/jco.2008.26.15_suppl.15611

10.1200/jco.2008.26.15_suppl.15611 · External reference

10.1159/000070310

10.1159/000070310 · External reference

Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC)

2008 · External reference

10.1038/sj.bjc.6602576

10.1038/sj.bjc.6602576 · External reference

10.1007/s00432-003-0534-7

10.1007/s00432-003-0534-7 · External reference

10.1002/cncr.21621

10.1002/cncr.21621 · External reference

10.1002/cncr.21041

10.1002/cncr.21041 · External reference

10.1007/s00280-013-2090-4

10.1007/s00280-013-2090-4 · External reference

10.1097/01.coc.0000135924.94955.16

10.1097/01.coc.0000135924.94955.16 · External reference

10.1023/a:1012543223020

10.1023/a:1012543223020 · External reference

10.1007/s00280-005-0095-3

10.1007/s00280-005-0095-3 · External reference

10.1093/jjco/hyi021

10.1093/jjco/hyi021 · External reference

10.1023/a:1008352123009

10.1023/a:1008352123009 · External reference

10.1023/b:drug.0000011797.09549.53

10.1023/b:drug.0000011797.09549.53 · External reference

10.1159/000070622

10.1159/000070622 · External reference

10.1186/1471-2407-5-61

10.1186/1471-2407-5-61 · External reference

10.1200/jco.2010.28.15_suppl.e14654

10.1200/jco.2010.28.15_suppl.e14654 · External reference

10.1007/s10620-007-9885-2

10.1007/s10620-007-9885-2 · External reference

10.1093/annonc/mdi046

10.1093/annonc/mdi046 · External reference

10.1038/sj.bjc.6601736

10.1038/sj.bjc.6601736 · External reference

10.1097/01.coc.0000203742.22828.bb

10.1097/01.coc.0000203742.22828.bb · External reference

10.1093/annonc/mdl956

10.1093/annonc/mdl956 · External reference

10.1002/cncr.21741

10.1002/cncr.21741 · External reference

10.1016/s1470-2045(11)70301-1

10.1016/s1470-2045(11)70301-1 · External reference

10.1007/s00280-009-1069-7

10.1007/s00280-009-1069-7 · External reference

10.1038/sj.bjc.6604628

10.1038/sj.bjc.6604628 · External reference

10.1038/sj.bjc.6603334

10.1038/sj.bjc.6603334 · External reference

Phase II study of gemcitabine and oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer

2009 · External reference

10.1007/s00280-009-1055-0

10.1007/s00280-009-1055-0 · External reference

10.1200/jco.2011.29.18_suppl.lba4032

10.1200/jco.2011.29.18_suppl.lba4032 · External reference

Multicentric Phase II randomized trial comparing chemoradiation with 5-fluorouracil, cisplatin and 50 GY versus chemotherapy alone with gemcitabine plus oxaliplatin for locally advanced biliary tract cancer

2012 · External reference

Phase II study of gemcitabine and oxaliplatin in unresectable gall bladder cancer

2010 · External reference

10.1093/annonc/mdl955

10.1093/annonc/mdl955 · External reference

10.1200/jco.2012.30.15_suppl.4032

10.1200/jco.2012.30.15_suppl.4032 · External reference

A Phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma

2006 · External reference

10.1111/j.1477-2574.2010.00197.x

10.1111/j.1477-2574.2010.00197.x · External reference

10.3349/ymj.2005.46.4.526

10.3349/ymj.2005.46.4.526 · External reference

10.1002/cncr.20753

10.1002/cncr.20753 · External reference

10.1007/s00280-011-1657-1

10.1007/s00280-011-1657-1 · External reference

10.1007/s00280-010-1443-5

10.1007/s00280-010-1443-5 · External reference

10.1002/cncr.21591

10.1002/cncr.21591 · External reference

Phase II study of fixed dose-rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced bile duct cancer: DAEGU GYEOUNGBUK oncology group

2010 · External reference

10.1038/sj.bjc.6601796

10.1038/sj.bjc.6601796 · External reference

10.1245/s10434-007-9539-9

10.1245/s10434-007-9539-9 · External reference

10.1200/jco.2005.51.008

10.1200/jco.2005.51.008 · External reference

10.1200/jco.2009.27.15_suppl.e15581

10.1200/jco.2009.27.15_suppl.e15581 · External reference

10.1200/jco.2009.27.15_suppl.e15527

10.1200/jco.2009.27.15_suppl.e15527 · External reference

10.1002/cncr.22902

10.1002/cncr.22902 · External reference

10.1200/jco.2009.27.15_suppl.e15510

10.1200/jco.2009.27.15_suppl.e15510 · External reference

10.1200/jco.2009.27.15_suppl.e15516

10.1200/jco.2009.27.15_suppl.e15516 · External reference

10.1200/jco.2012.30.15_suppl.4031

10.1200/jco.2012.30.15_suppl.4031 · External reference

10.1038/sj.bjc.6605377

10.1038/sj.bjc.6605377 · External reference

10.1007/s12029-008-9037-8

10.1007/s12029-008-9037-8 · External reference

10.1159/000328021

10.1159/000328021 · External reference

10.1159/000320462

10.1159/000320462 · External reference

10.1097/01.coc.0000258124.72884.7a

10.1097/01.coc.0000258124.72884.7a · External reference

10.1016/s1533-0028(11)70509-6

10.1016/s1533-0028(11)70509-6 · External reference

10.1093/oxfordjournals.annonc.a058932

10.1093/oxfordjournals.annonc.a058932 · External reference

10.1056/nejmoa073149

10.1056/nejmoa073149 · External reference

10.1056/nejmoa1304369

10.1056/nejmoa1304369 · External reference

Systemic treatment of biliary tract cancer

2013 · External reference

10.1093/oxfordjournals.annonc.a010676

10.1093/oxfordjournals.annonc.a010676 · External reference

10.1093/jjco/hym116

10.1093/jjco/hym116 · External reference

10.3904/kjim.2013.28.5.515

10.3904/kjim.2013.28.5.515 · External reference

10.1016/j.critrevonc.2013.05.010

10.1016/j.critrevonc.2013.05.010 · External reference

10.1016/j.ejca.2012.08.003

10.1016/j.ejca.2012.08.003 · External reference